Randomised Phase II Trial of Neoadjuvant Weekly Paclitaxel Plus Carboplatin Compared to Weekly Paclitaxel Alone Followed in Both Arms by Doxorubicin and Cyclophosphamide for Operable or Locally Advanced Basal-like Subtype Breast Cancer Correlating BRCA-1 mRNA and Protein Expression With Carboplatin Response
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Cyclophosphamide; Doxorubicin; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 19 Jun 2013 Biomarkers information updated
- 06 Feb 2008 New trial record.